Autolus Therapeutics plc Long-Term Debt
Autolus Therapeutics plc (AUTL) had Long-Term Debt of $0 as of 2019-12-31, per its 20-F filed 2020-03-03.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebtNoncurrent · last filed 2020-03-03
- 2019-12-31: Long-term Debt, Excluding Current Maturities $0.00.
- 2019-09-30: Long-term Debt, Excluding Current Maturities $30.00K.
- 2019-06-30: Long-term Debt, Excluding Current Maturities $121.00K.
- 2018-12-31: Long-term Debt, Excluding Current Maturities $285.00K.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2019-12-31 | $0.00 20-F · filed 2020-03-03 |
| 2019-09-30 | $30.00K 6-K · filed 2019-11-07 |
| 2019-06-30 | $121.00K 6-K · filed 2019-08-08 |
| 2018-12-31 | $285.00K 20-F · filed 2020-03-03 |
| 2018-09-30 | $380.00K 20-F · filed 2019-02-25 |
| 2017-09-30 | $763.00K 20-F · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 |